Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Towse, A.
Right arrow Articles by Moses, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Towse, A.
Right arrow Articles by Moses, A. C.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 18, Issue 8 1195-1197, Copyright © 1995 by American Diabetes Association

ARTICLES

Local reaction secondary to insulin injection. A potential role for latex antigens in insulin vials and syringes

A Towse, M O'Brien, FJ Twarog, J Braimon and AC Moses
Division of Endocrinology and Metabolism, Charles A. Dana Research Institute, Boston, Massachusetts, USA.

OBJECTIVE--To evaluate the possibility that latex antigens (natural rubber) can contribute to or cause local sensitivity at insulin injection sites. CASE--A subject with documented local cutaneous allergic reactions at the site of insulin injections and with systemic latex allergy manifested as anaphylaxis was tested with intradermal injections of insulin diluent from two manufacturers and with two brands of insulin syringes. RESULTS--The subject had high titer anti-latex Ige and elevated total levels of IgE in serum. Anti-insulin IgG and IgE antibodies were absent. Erythema and wheals occurred at the sites of intradermal injection of insulin therapy components (insulin diluent and syringes) that contain natural latex rubber but not at the site of injection of insulin therapy components that do not contain natural latex rubber. CONCLUSIONS--Small quantities of natural latex rubber antigens in insulin injection materials can be sufficient to produce local cutaneous reactions at the site of insulin injection in individuals highly allergic to natural latex rubber.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
R. G. Hamilton, R. H. Brown, M. A. Veltri, E. R. Feroli, M. N. Primeau, J. F. Schauble, and N. F. Adkinson Jr.
Administering pharmaceuticals to latex-allergic patients from vials containing natural rubber latex closures
Am. J. Health Syst. Pharm., September 1, 2005; 62(17): 1822 - 1827.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
D. L. Hepner and M. C. Castells
Latex Allergy: An Update
Anesth. Analg., April 1, 2003; 96(4): 1219 - 1229.
[Full Text] [PDF]

Home page
 NEJMHome page
M.A.B. Roest, S. Shaw, and D.I. Orton
Insulin-Injection-Site Reactions Associated with Type I Latex Allergy
N. Engl. J. Med., January 16, 2003; 348(3): 265 - 266.
[Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
R. P. Hoffman
Latex Hypersensitivity in a Child With Diabetes
Arch Pediatr Adolesc Med, March 1, 2000; 154(3): 281 - 282.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1995 by the American Diabetes Association.